联合国高级埃博拉协调员表示，刚果民主共和国的埃博拉疫情正在指数级增长，已成为该国历史上最致命的疫情1。根据报告，该疫情已累计超过5000例感染和2500例死亡，其中半数死亡发生在过去20天内1。这场危机由罕见的Bundibugyo埃博拉病毒引起，其传播速度是2014-2016西非疫情的三倍1。疫情最初于2026年初在刚果东北部伊图里省检出，官方随后于2026年5月15日宣布了这一公共卫生紧急事件1。
世界卫生组织已宣布将向刚果民主共和国提供7万剂Ervebo埃博拉疫苗以帮助控制疫情1。其中2万剂将用于第三阶段临床试验，5万剂将分配给一线和卫生工作者1。然而，Bundibugyo病毒株目前尚无经批准的疫苗或治疗方法，而Ervebo疫苗已获批用于更常见的扎伊尔株埃博拉病毒1。
The Democratic Republic of Congo is facing an unprecedented health crisis as its Ebola outbreak expands at an exponential rate, according to UN officials.1 The epidemic has already surpassed 5,000 confirmed infections and resulted in more than 2,500 deaths, making it the deadliest outbreak in the country's history.1 The affected area now covers a territory larger than France in size.1
The outbreak is caused by the rare Bundibugyo Ebola virus strain, which has proven particularly aggressive—spreading three times faster than the 2014-2016 West African epidemic.1 The situation has deteriorated markedly in recent weeks, with half of all deaths occurring within the past 20 days.1 The virus was first detected in early 2026 in Ituri Province in the northeastern region of the DRC, and the government officially announced the outbreak on May 15, 2026.1
To combat the crisis, the World Health Organization has committed to providing 70,000 doses of Ervebo vaccine to the DRC.1 Of these doses, 20,000 will be allocated to phase three clinical trials and 50,000 will be distributed to frontline workers and healthcare personnel.1 While Ervebo has already been approved for use against the more common Zaire strain of Ebola, the Bundibugyo variant currently circulating in the DRC has no approved vaccine or treatment options available.1
评论
还没有评论，欢迎留下第一条。